Implications of laboratory diagnosis on brucellosis therapy

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 7, 2011, Pages 833-845

  Al Dahouk, Sascha ^a,b   Nöckler, Karsten ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

antibiotic therapy; Brucella; culture; human brucellosis; laboratory diagnosis; molecular detection; serologic tests

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIUM ANTIBODY; BRUCELLA ANTIBODY; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PLACEBO; RIFAMPICIN; ROSE BENGAL; STREPTOMYCIN; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ANTIBODY TITER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BONE MARROW CULTURE; BRUCELLA; BRUCELLOSIS; CLINICAL FEATURE; COOMBS TEST; CULTURE TECHNIQUE; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SURVEILLANCE; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; GRAM NEGATIVE SEPSIS; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; LABORATORY TEST; MOLECULAR DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SEROLOGY; SINGLE DRUG DOSE; SYMPTOM; ZOONOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TYPING TECHNIQUES; BRUCELLA; BRUCELLOSIS; CATTLE; CATTLE DISEASES; DNA, BACTERIAL; DOXYCYCLINE; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; POLYMERASE CHAIN REACTION; RIFAMPIN; SEROLOGIC TESTS; STREPTOMYCIN;

EID: 79961199546     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.55     Document Type: Review

References (106)

1. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg. Infect. Dis. 11(8), 1180-1185 (2005). (Pubitemid 41045323)
2. Godfroid J, Cloeckaert A, Liautard JP et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36(3), 313-326 (2005). (Pubitemid 40716368)
3. Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int. J. Syst. Evol. Microbiol. 57(11), 2688-2693 (2007). (Pubitemid 350187441)
4. Scholz HC, Hubalek Z, Sedlácek I et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int. J. Syst. Evol. Microbiol. 58(2), 375-382 (2008). (Pubitemid 351298409)
5. Scholz HC, Hofer E, Vergnaud G et al. Isolation of Brucella microti from mandibular lymph nodes of red foxes, Vulpes vulpes, in lower Austria. Vector Borne Zoonotic Dis. 9(2), 153-156 (2009).
6. Scholz HC, Hubalek Z, Nesvadbova J et al. Isolation of Brucella microti from soil. Emerg. Infect. Dis. 14(8), 1316-1317 (2008).
7. Scholz HC, Nöckler K, Göllner C et al. Brucella inopinata sp. nov., isolated from a breast implant infection. Int. J. Syst. Evol. Microbiol. 60(4), 801-808 (2010).
8. Tiller RV, Gee JE, Frace MA et al. Characterization of novel Brucella strains originating from wild native rodent species in North Queensland, Australia. Appl. Environ. Microbiol. 76(17), 5837-5845 (2010).
9. Schlabritz-Loutsevitch NE, Whatmore AM, Quance CR et al. A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J. Med. Primatol. 38(1), 70-73 (2009).
10. Tiller RV, Gee JE, Lonsway DR et al. Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiol. 10, 23 (2010).
11. World Health Organization. Fact sheet N173. World Health Organization, Geneva, Switzerland (1997).
12. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect. Dis. 6(2), 91-99 (2006). (Pubitemid 43138907)
13. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N. Engl. J. Med. 352(22), 2325-2336 (2005).
14. Lucero NE, Ayala SM, Escobar GI, Jacob NR. Brucella isolated in humans and animals in Latin America from 1968 to 2006. Epidemiol. Infect. 136(4), 496-503 (2008). (Pubitemid 351344521)
15. Refai M. Incidence and control of brucellosis in the Near East region. Vet. Microbiol. 90(1-4), 81-110 (2002). (Pubitemid 35279871)
16. Wolfram JH, Butaev MK, Duysheev A et al. Brucellosis: a transboundary zoonotic disease. Epidemiology chapter. Vaccine 28(Suppl. 5), F77-F84 (2010).
17. McDermott JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet. Microbiol. 90(1-4), 111-134 (2002). (Pubitemid 35279872)
18. Taleski V, Zerva L, Kantardjiev T et al. An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe. Vet. Microbiol. 90(1-4), 147-155 (2002). (Pubitemid 35279874)
19. Memish ZA, Balkhy HH. Brucellosis and international travel. J. Travel Med. 11(1), 49-55 (2004). (Pubitemid 38198776)
20. Marcotty T, Matthys F, Godfroid J et al. Zoonotic tuberculosis and brucellosis in Africa: neglected zoonoses or minor public-health issues? The outcomes of a multi-disciplinary workshop. Ann. Trop. Med. Parasitol. 103(5), 401-411 (2009).
21. Godfroid J, Käsbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Vet. Microbiol. 90(1-4), 135-145 (2002). (Pubitemid 35279873)
22. Godfroid J. Brucellosis in wildlife. Rev. Sci. Tech. 21(2), 277-286 (2002).
23. Gwida M, Al Dahouk S, Melzer F, Rösler U, Neubauer H, Tomaso H. Brucellosis - regionally emerging zoonotic disease? Croat. Med. J. 51(4), 289-295 (2010).
24. Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75(4), 195-211 (1996). (Pubitemid 26260237)
25. Buzgan T, Karahocagil MK, Irmak H et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int. J. Infect. Dis. 14(6), e469-e478 (2010).
26. Al Dahouk S, Neubauer H, Hensel A et al. Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg. Infect. Dis. 13(12), 1895-1900 (2007). (Pubitemid 350248492)
27. Ariza J, Bosilkovski M, Cascio A et al.; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 4(12), e317 (2007).
28. Corbel MJ. Treatment of human brucellosis. In:Brucellosis in Humans and Animals (Chapter 5). Corbel MJ, Elberg SS, Cosivi O (Eds).World Health Organization, Geneva, Switzerland, 36-41 (2006).
29. Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ 336(7646), 701-704 (2008). (Pubitemid 351481212)
30. Solera J. Update on brucellosis: therapeutic challenges. Int. J. Antimicrob. Agents 36(Suppl. 1), S18-S20 (2010).
31. Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis - a review of the literature. Part I: techniques for direct detection and identification of Brucella spp. Clin. Lab. 49(9-10), 487-505 (2003). (Pubitemid 37266114)
32. Yagupsky P. Detection of brucellae in blood cultures. J. Clin. Microbiol. 37(11), 3437-3442 (1999). (Pubitemid 29491070)
33. Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J. Infect. 40(1), 59-63 (2000). (Pubitemid 30157775)
34. Kadanali A, Ozden K, Altoparlak U, Erturk A, Parlak M. Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations. Infection 37(1), 67-69 (2009).
35. Espinosa BJ, Chacaltana J, Mulder M et al. Comparison of culture techniques at different stages of brucellosis. Am. J. Trop. Med. Hyg. 80(4), 625-627 (2009).
36. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect. Dis. 7(12), 775-786 (2007). (Pubitemid 350152041)
37. Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis - the value of bone marrow culture. J. Infect. Dis. 153(1), 122-125 (1986). (Pubitemid 16212461)
38. Mantur BG, Mulimani MS, Bidari LH, Akki AS, Tikare NV. Bacteremia is as unpredictable as clinical manifestations in human brucellosis. Int. J. Infect. Dis. 12(3), 303-307 (2008). (Pubitemid 351539108)
39. Baysallar M, Aydogan H, Kilic A, Kucukkaraaslan A, Senses Z, Doganci L. Evaluation of the BacT/ALERT and BACTEC 9240 automated blood culture systems for growth time of Brucella species in a Turkish tertiary hospital. Med. Sci. Monit. 12(7), BR235-BR238 (2006). (Pubitemid 44042831)
40. Cetin ES, Kaya S, Demirci M, Aridogan BC. Comparison of the BACTEC blood culture system versus conventional methods for culture of normally sterile body fluids. Adv. Ther. 24(6), 1271-1277 (2007). (Pubitemid 351612233)
41. Mantur BG, Bidari LH, Akki AS, Mulimani MS, Tikare NV. Diagnostic yield of blood clot culture in the accurate diagnosis of enteric fever and human brucellosis. Clin. Lab. 53(1-2), 57-61 (2007). (Pubitemid 46350983)
42. Mantur BG, Mangalgi SS. Evaluation of conventional Castañeda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J. Clin. Microbiol. 42(9), 4327-4328 (2004). (Pubitemid 39296169)
43. Yagupsky P. Use of the BACTEC Myco/F Lytic medium for detection of Brucella melitensis bacteremia. J. Clin. Microbiol. 42(5), 2207-2208 (2004). (Pubitemid 38637843)
44. Rovery C, Rolain JM, Raoult D, Brouqui P. Shell vial culture as a tool for isolation of Brucella melitensis in chronic hepatic abscess. J. Clin. Microbiol. 41(9), 4460-4461 (2003). (Pubitemid 37099732)
45. Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. Institut National de la Recherche Agronomique, Paris, France (1988).
46. Barham WB, Church P, Brown JE, Paparello S. Misidentification of Brucella species with use of rapid bacterial identification systems. Clin. Infect. Dis. 17(6), 1068-1069 (1993). (Pubitemid 23358762)
47. Elsaghir AA, James EA. Misidentification of Brucella melitensis as Ochrobactrum anthropi by API 20 NE. J. Med. Microbiol. 52(5), 441-442 (2003). (Pubitemid 36589172)
48. Al Dahouk S, Scholz HC, Tomaso H et al. Differential phenotyping of Brucella species using a newly developed semi-automated metabolic system. BMC Microbiol. 10, 269 (2010).
49. Rich M, Bannatyne RM, Memish ZA. Direct urease test on BACTEC blood cultures: early presumptive diagnosis of brucellosis in an area of endemicity. J. Clin. Microbiol. 38(4), 1706 (2000). (Pubitemid 30216724)
50. Rich M, Memish ZA. Presumptive diagnosis of brucellosis from contaminated blood cultures in an area of endemicity. Br. J. Biomed. Sci. 61(2), 93-94 (2004). (Pubitemid 38879535)
51. Wellinghausen N, Nöckler K, Sigge A, Bartel M, Essig A, Poppert S. Rapid detection of Brucella spp. in blood cultures by fluorescence in situ hybridization. J. Clin. Microbiol. 44(5), 1828-1830 (2006). (Pubitemid 43726275)
52. Qu Q, Zhu Z, Wang Y et al. Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay. J. Microbiol. Methods 79(1), 121-123 (2009).
53. Al Dahouk S, Nöckler K, Scholz HC, Tomaso H, Bogumil R, Neubauer H. Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections. J. Immunol. Methods 309(1-2), 34-47 (2006). (Pubitemid 43190800)
54. Ferreira L, Vega Castaño S, Sánchez-Juanes F et al. Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures. PLoS ONE 5(12), e14235 (2010).
55. Ariza J, Bosch J, Gudiol F, Liñares J, Viladrich PF, Martín R. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob. Agents Chemother. 30(6), 958-960 (1986). (Pubitemid 17209161)
56. Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis - a review of the literature. Part II: serological tests for brucellosis. Clin. Lab. 49(11-12), 577-589 (2003). (Pubitemid 37493456)
57. Ariza J, Pellicer T, Pallarés R, Foz A, Gudiol F. Specific antibody profile in human brucellosis. Clin. Infect. Dis. 14(1), 131-140 (1992).
58. Casanova A, Ariza J, Rubio M, Masuet C, Díaz R. Brucellacapt versus classical tests in the serological diagnosis and management of human brucellosis. Clin. Vaccine Immunol. 16(6), 844-851 (2009).
59. Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp. Immunol. Microbiol. Infect. Dis. 33(5), 435-442 (2010).
60. Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J. Med. Microbiol. 54(5), 457-461 (2005). (Pubitemid 40605162)
61. Araj GF. Update on laboratory diagnosis of human brucellosis. Int. J. Antimicrob. Agents 36 (Suppl. 1), 12-17 (2010).
62. Konstantinidis A, Minas A, Pournaras S et al. Evaluation and comparison of fluorescence polarization assay with three of the currently used serological tests in diagnosis of human brucellosis. Eur. J. Clin. Microbiol. Infect. Dis. 26(10), 715-721 (2007). (Pubitemid 47373414)
63. Lucero NE, Escobar GI, Ayala SM, Silva Paulo P, Nielsen K. Fluorescence polarization assay for diagnosis of human brucellosis. J. Med. Microbiol. 52(10), 883-887 (2003). (Pubitemid 37297317)
64. Ruiz-Mesa JD, Sánchez-Gonzalez J, Reguera JM, Martín L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin. Microbiol. Infect. 11(3), 221-225 (2005). (Pubitemid 40352769)
65. Sharma R, Chisnall C, Cooke RP. Evaluation of in-house and commercial immunoassays for the sero-diagnosis of brucellosis in a non-endemic low prevalence population. J. Infect. 56(2), 108-113 (2008).
66. Zeytinoǧlu A, Turhan A, Altuǧlu I, Bilgiç A, Abdoel TH, Smits HL. Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis. Clin. Chem. Lab. Med. 44(2), 180-184 (2006). (Pubitemid 43237962)
67. Mantur B, Parande A, Amarnath S et al. ELISA versus conventional methods of diagnosing endemic brucellosis. Am. J. Trop. Med. Hyg. 83(2), 314-318 (2010).
68. Gómez MC, Nieto JA, Rosa C et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin. Vaccine Immunol. 15(6), 1031-1033 (2008). (Pubitemid 351967001)
69. Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int. J. Infect. Dis. 14(3), e250-e253 (2010).
70. Araj GF, Kattar MM, Fattouh LG, Bajakian KO, Kobeissi SA. Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin. Diagn. Lab. Immunol. 12(11), 1334-1335 (2005). (Pubitemid 41626606)
71. Prince HE, Lopez J, Yeh C et al. Performance characteristics of the Euroimmun enzyme-linked immunosorbent assay kits for Brucella IgG and IgM. Diagn. Microbiol. Infect. Dis. 65(2), 99-102 (2009).
72. Díaz R, Ariza J, Alberola I, Casanova A, Rubio MF. Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis. Clin. Vaccine Immunol. 13(11), 1190-1196 (2006). (Pubitemid 46768875)
73. Cakan G, Bezirci FB, Kacka A et al. Assessment of diagnostic enzyme-linked immunosorbent assay kit and serological markers in human brucellosis. Jpn. J. Infect. Dis. 61(5), 366-370 (2008).
74. Al Dahouk S, Neubauer H, Tomaso H. Brucella. In:Molecular Detection of Human Bacterial Pathogens (Chapter 54). Liu D (Ed.).Taylor & Francis CRC Press, Boca Raton, FL, USA, 629-646 (2011).
75. Navarro E, Casao MA, Solera J. Diagnosis of human brucellosis using PCR. Expert Rev. Mol. Diagn. 4(1), 115-123 (2004). (Pubitemid 38094252)
76. Colmenero JD, Morata P, Ruiz-Mesa JD et al. Multiplex real-time polymerase chain reaction: a practical approach for rapid diagnosis of tuberculous and brucellar vertebral osteomyelitis. Spine 35(24), 1392-1396 (2010).
77. Colmenero JD, Queipo-Ortuño MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J. Neurol. Neurosurg. Psychiatry 76(7), 1025-1027 (2005). (Pubitemid 40909571)
78. Debeaumont C, Falconnet PA, Maurin M. Real-time PCR for detection of Brucella spp. DNA in human serum samples. Eur. J. Clin. Microbiol. Infect. Dis. 24(12), 842-845 (2005). (Pubitemid 43042792)
79. Queipo-Ortuño MI, Colmenero JD, Bermudez P, Bravo MJ, Morata P. Rapid differential diagnosis between extrapulmonary tuberculosis and focal complications of brucellosis using a multiplex real-time PCR assay. PLoS ONE 4(2), e4526 (2009).
80. Queipo-Ortuño MI, Colmenero JD, Muñoz N, Baeza G, Clavijo E, Morata P. Rapid diagnosis of Brucella epididymo-orchitis by real-time polymerase chain reaction assay in urine samples. J. Urol. 176(5), 2290-2293 (2006). (Pubitemid 44740179)
81. Queipo-Ortuño MI, Colmenero JD, Reguera JM et al. Rapid diagnosis of human brucellosis by SYBR Green I-based real-time PCR assay and melting curve analysis in serum samples. Clin. Microbiol. Infect. 11(9), 713-718 (2005). (Pubitemid 41167336)
82. Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J. Clin. Microbiol. 45(4), 1211-1218 (2007). (Pubitemid 46626487)
83. Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ. Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J. Clin. Microbiol. 39(4), 1661-1664 (2001). (Pubitemid 32275490)
84. Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J. Trop. Med. Hyg. 95(4), 271-275 (1992).
85. Al Dahouk S, Nöckler K, Scholz HC, Pfeffer M, Neubauer H, Tomaso H. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin. Chem. Lab. Med. 45(11), 1464-1470 (2007). (Pubitemid 350036562)
86. Gee JE, De BK, Levett PN, Whitney AM, Novak RT, Popovic T. Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J. Clin. Microbiol. 42(8), 3649-3654 (2004). (Pubitemid 39045694)
87. García-Yoldi D, Marín CM, de Miguel MJ, Muñoz PM, Vizmanos JL, López-Goñi I. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clin. Chem. 52(4), 779-781 (2006).
88. Mayer-Scholl A, Draeger A, Göllner C, Scholz HC, Nöckler K. Advancement of a multiplex PCR for the differentiation of all currently described Brucella species. J. Microbiol. Methods 80(1), 112-114 (2010).
89. López-Goñi I, García-Yoldi D, Marín CM et al. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J. Clin. Microbiol. 46(10), 3484-3487 (2008).
90. Al Dahouk S, Tomaso H, Nöckler K, Neubauer H. The detection of Brucella spp. using PCR-ELISA and real-time PCR assays. Clin. Lab. 50(7-8), 387-394 (2004). (Pubitemid 39149434)
91. Queipo-Ortuño MI, Colmenero JD, Macias M, Bravo MJ, Morata P. Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis. Clin. Vaccine Immunol. 15(2), 293-296 (2008). (Pubitemid 352025522)
92. Maas KS, Méndez M, Zavaleta M et al. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am. J. Trop. Med. Hyg. 76(4), 698-702 (2007). (Pubitemid 351627710)
93. Queipo-Ortuño MI, Tena F, Colmenero JD, Morata P. Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR. Eur. J. Clin. Microbiol. Infect. Dis. 27(2), 109-114 (2008).
94. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin. Infect. Dis. 46(12), 131-136 (2008).
95. Navarro E, Segura JC, Castaño MJ, Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin. Infect. Dis. 42(9), 1266-1273 (2006).
96. Bounaadja L, Albert D, Chénais B et al. Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes. Vet. Microbiol. 137(1-2), 156-164 (2009).
97. Hinić V, Brodard I, Thomann A et al. Novel identification and differentiation of Brucella melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae suitable for both conventional and real-time PCR systems. J. Microbiol. Methods 75(2), 375-378 (2008).
98. Castaño MJ, Solera J. Chronic brucellosis and persistence of Brucella melitensis DNA. J. Clin. Microbiol. 47(7), 2084-2089 (2009).
99. Queipo-Ortuño MI, Colmenero JD, Bravo MJ, García- Ordoñez MA, Morata P. Usefulness of a quantitative real-time PCR assay using serum samples to discriminate between inactive, serologically positive and active human brucellosis. Clin. Microbiol. Infect. 14(12), 1128-1134 (2008).
100. Morata P, Queipo-Ortuño MI, Reguera JM, García-Ordoñez MA, Pichardo C, Colmenero JD. Posttreatment follow-up of brucellosis by PCR assay. J. Clin. Microbiol. 37(12), 4163-4166 (1999).
101. Le Flèche P, Jacques I, Grayon M et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol. 6, 9 (2006).
102. Whatmore AM, Shankster SJ, Perrett LL et al. Identification and characterization of variable-number tandem-repeat markers for typing of Brucella spp. J. Clin. Microbiol. 44(6), 1982-1993 (2006). (Pubitemid 43902143)
103. Al Dahouk S, Le Flèche P, Nöckler K et al. Evaluation of Brucella MLVA typing for human brucellosis. J. Microbiol. Methods 69(1), 137-145 (2007). (Pubitemid 46437272)
104. Al Dahouk S, Hagen RM, Nöckler K et al. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. Chemotherapy 51(6), 352-356 (2005). (Pubitemid 41546712)
105. Young EJ. Human brucellosis. Rev. Infect. Dis. 5(5), 821-842 (1983).
106. Özkurt Z, Erol S, Tasyaran MA, Kaya A. Detection of Brucella melitensis by the BacT/Alert automated system and Brucella broth culture. Clin. Microbiol. Infect. 8(11), 749-752 (2002). (Pubitemid 35385874)